Systemic scleroderma
Systemic scleroderma is an autoimmune disorder characterized by the buildup of fibrosis in the skin and internal organs due to the excess production of collagen.
Overview
In systemic scleroderma, the immune system malfunctions and attacks the body's own tissues. The resulting fibrosis (thickening and hardening of tissue) can affect the skin and vital organs, including the esophagus, heart, lungs, and kidneys.
Common Signs and Symptoms
- Raynaud phenomenon: Fingers and toes turning white or blue in response to cold or stress.
- Skin changes: Puffy hands, followed by thickening and hardening (sclerodactyly).
- Dermal features: Open sores (ulcers) on fingers, painful bumps (calcinosis), or enlarged blood vessels (telangiectasia).
- Internal involvement: Heartburn, difficulty swallowing, shortness of breath, or kidney problems.
Types
- Limited cutaneous systemic scleroderma: Fibrosis typically affects only the hands, arms, and face.
- Diffuse cutaneous systemic scleroderma: Fibrosis affects large areas of skin, including the torso, and often involves internal organs with rapid progression.
- Systemic sclerosis sine scleroderma: Fibrosis affects internal organs but does not involve the skin.
Causes
The exact cause is unknown, but variations in several genes—particularly those in the HLA complex—influence risk. Other genes, such as IRF5 and STAT4, which are involved in immune response, are also associated with the condition. Genetic factors likely interact with environmental triggers to determine the risk of developing the disorder.
Inheritance
Most cases are sporadic, occurring in people with no family history of the condition. While it can occasionally run in families, there is no clear pattern of inheritance. Inheriting a genetic variation linked to systemic scleroderma does not guarantee that an individual will develop the condition.
